Cargando…

Bullous Pemphigoid Associated With Pembrolizumab Therapy for Non-Small-Cell Lung Cancer: A Case Report

Pembrolizumab is an immune checkpoint inhibitor being increasingly used as immunotherapy for a multitude of cancers. With the increasing use of these agents, various immune-related adverse events are being recognized. Lichenoid reaction, pruritus, and eczema are well-established cutaneous side effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chatterjee, Tulika, Rashid, Thomas F, Syed, Salman B, Roy, Moni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890109/ https://www.ncbi.nlm.nih.gov/pubmed/35251840 http://dx.doi.org/10.7759/cureus.21770

Ejemplares similares

When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022)

Combination Therapy of Plasma Exchange and Rituximab to Treat Cicatricial Pemphigoid and Bullous Pemphigoid
por: Kunadia, Anuj, et al.
Publicado: (2021)

Dyshidrosiform Bullous Pemphigoid: Case Reports and Review
por: Cohen, Philip R
Publicado: (2020)

A Case of Bullous Pemphigoid Associated With Nivolumab Therapy
por: Gotera, Nico, et al.
Publicado: (2022)

Delayed Onset of Bullous Pemphigoid Secondary to Nivolumab
por: Olsen, Eric, et al.
Publicado: (2023)

Hydrochlorothiazide vs Venlafaxine: Drug-induced Bullous Pemphigoid
por: Naramala, Srikanth, et al.
Publicado: (2019)

Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination
por: Shanshal, Mohammed
Publicado: (2022)

A Case of Severe Bullous Dermatitis With Mixed Bullous Pemphigoid and Pemphigus Vulgaris Cutaneous Manifestations
por: Burns, Reece D, et al.
Publicado: (2021)

Pembrolizumab-induced bullous pemphigoid
por: Sun, Christina W., et al.
Publicado: (2019)

Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022)

The Successful Treatment of COVID-19-Induced Bullous Pemphigoid With Dupilumab
por: Savoldy, Michelle A, et al.
Publicado: (2022)

A Case of Drug-Induced Bullous Pemphigoid With an Isomorphic Response and Updated Review of Koebnerization in Bullous Diseases
por: Ambur, Austin B, et al.
Publicado: (2021)

A Case of Bullous Pemphigoid: A Prevalent and Potentially Fatal Condition
por: Parellada, Jorge, et al.
Publicado: (2018)

Bullous Pemphigoid in a Centenarian Male Simulating Toxic Epidermal Necrolysis
por: Shakhashiro, Muna, et al.
Publicado: (2023)

Bullous Pemphigoid: A Spontaneous Presentation in a Patient With Chronic Kidney Disease
por: Brazen, Brett, et al.
Publicado: (2022)

Association of Bullous Pemphigoid with Malignancy: A Myth or Reality?
por: Fernandes, Joycelin, et al.
Publicado: (2014)

Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid
por: Chen, Fangyuan, et al.
Publicado: (2023)

Bullous Pemphigoid and Human Leukocyte Antigen (HLA)-DQA1: A Systematic Review
por: Hesari, Roksana, et al.
Publicado: (2023)

A Rare Case of Bullous Pemphigoid Secondary to Checkpoint Inhibitor Immunotherapy: A Tense Situation
por: Wesolow, Jacqueline T, et al.
Publicado: (2021)

A Case of Bullous Pemphigoid in a Five-Month-Old Female: A Rare Presentation
por: Ahmed, Mohamed, et al.
Publicado: (2023)

Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019)

Validation study of bullous pemphigoid and pemphigus vulgaris recording in routinely collected electronic primary healthcare records in England
por: Persson, Monica S M, et al.
Publicado: (2020)

Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports
por: Thomsen, Kenneth, et al.
Publicado: (2018)

Bullous Pemphigoid Limited to the Hands and Feet: A Rare Case of an Infantile Disease Pattern Seen in an Elderly Patient
por: Nellore, Aditya, et al.
Publicado: (2023)

Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid
por: Wang, Jianglin, et al.
Publicado: (2023)

Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid
por: Zhang, Xiaoyan, et al.
Publicado: (2021)

Dupilumab for the treatment of pembrolizumab‐induced bullous pemphigoid: A case report
por: Pop, Samantha R., et al.
Publicado: (2022)

Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab
por: Cardona, Andrés F., et al.
Publicado: (2021)

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
por: Qiu, Connie, et al.
Publicado: (2020)

Pembrolizumab-Associated Stevens-Johnson Syndrome in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report
por: Sandhu, Michael, et al.
Publicado: (2023)

Pembrolizumab-Induced Lichen Planus in a Patient With Non-Small-Cell Lung Carcinoma (NSCLC) That Correlates to Therapeutic Response
por: Sehbai, Aasim, et al.
Publicado: (2022)

Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
por: Beck, Kristen M., et al.
Publicado: (2016)

Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
por: Honigman, Anthony D., et al.
Publicado: (2019)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Bullous Iodide Rash
Publicado: (1909)

Bullous Systemic Lupus Erythematosus: A Case Report
por: Giri, Ganesh, et al.
Publicado: (2023)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Bullous pemphigoid during ustekinumab therapy
por: Le Guern, Aurore, et al.
Publicado: (2015)

Pembrolizumab-Induced Acute Skin Reaction: A Case Report and Review of Literature
por: Thomas, Mathew, et al.
Publicado: (2022)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dkikapuh2khespnv9gjarl09d0